Polyethylene wear and Paprosky map: age driven acetabular bone loss in cemented and cementless THA revisions
Archives of Public Health · 02.04.2026 · 18 (1)
DOI: 10.3889/aph.2026.6657 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Public Health, online erschienen am 02.04.2026. Verfasst von Darko Talevski und 10 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate acetabular bone loss patterns, classified by the Paprosky system, in cemented and cementless acetabular components revised for polyethylene wear–related aseptic loosening, and to determine whether age, time to revision, and body mass index (BMI) predict greater defect severity.
Methods
A retrospective cohort study was conducted involving 60 acetabular revision total hip arthroplasties, divided into cemented (n=30) and cementless (n=30) fixation groups. All revisions were undertaken for aseptic loosening attributed to polyethylene wear, with primary cups implanted within the Lewinnek “safe zone”. Cases with developmental dysplasia, inflammatory arthropathy, or prior infection were excluded. Baseline variables were age, sex, BMI, and time to revision. Acetabular bone loss was graded radiographically using the Paprosky classification (I, IIA, IIB, IIC, IIIA, IIIB). Group differences in Paprosky subtype distribution were tested with chi-square analysis. Ordered logistic regression was employed to examine predictors of increasing Paprosky rank, and multivariable logistic regression to evaluate predictors of severe defects (Paprosky III vs. I–II), with BMI as the primary exposure and adjustment for fixation type, age, sex, and time to revision.
Results
The Paprosky subtype distribution did not differ significantly between cemented and cementless cups (p=0.26). Higher age at revision was independently associated with more severe Paprosky categories (OR 1.08 per year, p=0.036), whereas fixation type showed only a non-significant trend toward higher severity for cementless components. BMI was not associated with severe acetabular defects, and cementless fixation showed a non-significant trend toward Paprosky III defects.
Conclusions
In patients with polyethylene wear–related aseptic loosening, acetabular defect severity according to Paprosky classification appears more closely related to patient age - and, by implication, cumulative time in situ - than to fixation concept or BMI. Cemented and cementless acetabular components showed similar Paprosky defect distributions, and BMI was not an independent predictor of severe bone loss. These findings underscore the central role of long-term wear and osteolysis in acetabular bone loss and support development of models that integrate time-dependent wear exposure, key implant characteristics, and advanced imaging-based assessment to guide timing and strategy of revision total hip arthroplasty.
Zitieren
APA
Talevski, D., Nancheva, J., Cirivri, J., Atanasov, N., Zoran, N., Vraniskoski, T., Petkov, N., Karevski, A., Vangelovska, Z., Ciriviri, D., & Jovanova, A. (2026). Polyethylene wear and Paprosky map: age driven acetabular bone loss in cemented and cementless THA revisions. Archives of Public Health, 18(1). https://doi.org/10.3889/aph.2026.6657
Vancouver
Talevski D, Nancheva J, Cirivri J, Atanasov N, Zoran N, Vraniskoski T, et al. Polyethylene wear and Paprosky map: age driven acetabular bone loss in cemented and cementless THA revisions. Archives of Public Health. 2026;18(1). doi:10.3889/aph.2026.6657
BibTeX
@article{Talevski2026,
author = {Talevski, Darko and Nancheva, Jasminka and Cirivri, Jasmin and Atanasov, Nenad and Zoran, Nestorovski and Vraniskoski, Tode and Petkov, Nenad and Karevski, Aleksandar and Vangelovska, Zorica and Ciriviri, Dusko and Jovanova, Aleksandra},
title = {Polyethylene wear and Paprosky map: age driven acetabular bone loss in cemented and cementless THA revisions},
journal = {Archives of Public Health},
year = {2026},
volume = {18},
number = {1},
doi = {10.3889/aph.2026.6657}
}
EUVIMED